This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Goldstein, L. B. Articles by Samsa, G. P. Search for Related Content PubMed PubMed Citation Articles by Goldstein, L. B. Articles by Samsa, G. P.

(Stroke. 1996;27:1473-1478.)
© 1996 American Heart Association, Inc.

Articles

US National Survey of Physician Practices for the Secondary and Tertiary Prevention of Ischemic Stroke

Medical Therapy in Patients With Carotid Artery Stenosis

Larry B. Goldstein, MD; Arthur J. Bonito, PhD; David B. Matchar, MD; Pamela W. Duncan, PhD Gregory P. Samsa, PhD

the Center for Health Policy Research and Education (L.B.G., A.J.B., D.B.M., P.W.D., G.P.S.), Divisions of Neurology (L.B.G.) and General Internal Medicine (D.B.M., G.P.S.), Department of Medicine, and Department of Community and Family Medicine (Biometry) (G.P.S.), Duke University, Durham, NC; Division of Neurology, Durham (NC) Department of Veterans Affairs Medical Center (L.B.G.); Research Triangle Institute, Research Triangle Park, NC (A.J.B.); and Center on Aging, University of Kansas, Kansas City (P.W.D.).

Correspondence to Larry B. Goldstein, MD, Box 3651, Duke University Medical Center, Durham, NC 27710. E-mail golds004@mc.duke.edu.

Background and Purpose Aspirin or other platelet antiaggregants and anticoagulants are commonly used in many types of patients at elevated stroke risk. However, relatively little is known concerning how practicing physicians use these medications in their patients with extracranial carotid artery stenosis. The identification of variations in practice may help to both direct specific educational efforts and guide further research.

Methods Between August 1993 and February 1994, we surveyed the stroke prevention practices of a stratified random sample of 2000 US physicians. The survey included clinical scenarios that probed the use of aspirin or other platelet antiaggregants and anticoagulants in symptomatic and asymptomatic patients with carotid artery stenoses of 50% to 70% or more than 70%, with and without known surgical contraindications.

Results Sixty-seven percent of those eligible completed the survey (n=1006). More than 85% of physicians responded that they always or often prescribe aspirin or other platelet antiaggregants regardless of degree of carotid artery stenosis, symptom status, or presence of surgical contraindications. However, the reported frequency of use of these medications varied independently according to physician specialty (P=.044). In contrast, in addition to physician specialty, the reported frequency of anticoagulant use varied independently with degree of carotid artery stenosis, symptom status, and presence of surgical contraindications (P<.0001 for each variable). Fifteen percent of physicians responded that they always or often use anticoagulants for asymptomatic patients with 50% to 70% carotid artery stenosis versus 43% who reported doing so for symptomatic patients with a similar degree of stenosis (P<.001); 28% often or always prescribe anticoagulants for asymptomatic patients with more than 70% carotid artery stenosis versus 49% who do so if symptoms are present (P<.001). The odds of noninternist primary care physicians responding that they always or often use anticoagulants were more than five times higher (odds ratio, 5.32; 95% confidence interval [CI], 3.79 to 7.45) than surgical specialists. Compared with surgical specialists, the odds ratios for the use of anticoagulants were 3.65 for internists (95% CI, 2.63 to 5.06) and 1.88 (95% CI, 1.40 to 2.53) for neurologists.

Conclusions These data show the following: (1) Aspirin or other platelet antiaggregants are used by most physicians regardless of degree of carotid artery stenosis, symptom status, or presence of surgical contraindications; (2) anticoagulants are prescribed selectively, with each of these variables influencing their use; and (3) the use of both classes of agents varies with physician specialty training.

Key Words: anticoagulants • antiplatelet agents • aspirin • carotid stenosis • stroke prevention

This article has been cited by other articles:

				G. P. Samsa, D. B. Matchar, L. B. Goldstein, A. J. Bonito, L. J. Lux, D. M. Witter, and J. Bian Quality of Anticoagulation Management Among Patients With Atrial Fibrillation: Results of a Review of Medical Records From 2 Communities Arch Intern Med, April 10, 2000; 160(7): 967 - 973. [Abstract] [Full Text] [PDF]

				F. M. Hecht, I. B. Wilson, A. W. Wu, R. L. Cook, B. J. Turner, and for the Society of General Internal Medicine AIDS Optimizing Care for Persons with HIV Infection Ann Intern Med, July 20, 1999; 131(2): 136 - 143. [Abstract] [Full Text] [PDF]

				R. F. Gillum and C. T. Sempos The End of the Long-term Decline in Stroke Mortality in the United States? Stroke, August 1, 1997; 28(8): 1527 - 1529. [Full Text]

				J. R. Webster Jr and J. Feinglass Stroke Patients, "Managed Care," and Distributive Justice JAMA, July 9, 1997; 278(2): 161 - 162. [Abstract] [PDF]

				L. B. Goldstein, A. Farmer, and D. B. Matchar Primary Care Physician–Reported Secondary and Tertiary Stroke Prevention Practices : A Comparison Between the United States and the United Kingdom Stroke, April 1, 1997; 28(4): 746 - 751. [Abstract] [Full Text]